Castle Biosciences CSTL Finance Lease Liability, Current
Finance Lease Liability, Current at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityCurrent.
The official record: Castle Biosciences’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's finance lease liability, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's finance lease liability, current?
- Castle Biosciences (CSTL) reported finance lease liability, current of $102K in Q4 2025.
- How has Castle Biosciences's finance lease liability, current changed year-over-year?
- Castle Biosciences's finance lease liability, current increased by 1.0% year-over-year, from $101K to $102K.
- What is the long-term trend for Castle Biosciences's finance lease liability, current?
- Over 4 years (2021 to 2025), Castle Biosciences's finance lease liability, current has grown at a -0.7% compound annual growth rate (CAGR), from $105K to $102K.
- What does finance lease liability, current mean?
- Finance lease liabilities (current) represent the portion of lease obligations that are due to be paid within the next twelve months. These obligations arise from long-term contracts where the company effectively controls the leased asset. This metric is critical for assessing near-term liquidity and cash flow requirements.